Market Overview - U.S. stocks experienced a decline, with the Nasdaq Composite falling over 1% on Thursday, while the Dow decreased by 0.64% to 45,824.16 and the S&P 500 dropped 1% to 6,571.28 [1] - Energy shares increased by 0.5%, while health care stocks fell by 1.4% on the same day [1] Company Performance - Accenture (NYSE: ACN) reported better-than-expected fourth-quarter 2025 results, with earnings of $3.03 per share, surpassing the analyst consensus estimate of $2.96, and sales of $17.60 billion, slightly exceeding the estimate of $17.36 billion [2] Commodity Market - Oil prices decreased by 0.2% to $64.88, while gold also fell by 0.2% to $3,761.50. Silver prices rose by 1.2% to $44.725, and copper prices dropped by 1% to $4.7660 [5] European Market - European shares were lower, with the eurozone's STOXX 600 falling by 0.52%, Spain's IBEX 35 Index down by 0.18%, London's FTSE 100 down by 0.24%, Germany's DAX 40 dipping by 0.62%, and France's CAC 40 falling by 0.46% [6] Asian Market - Asian markets closed mostly lower, with Japan's Nikkei 225 gaining 0.27%, while Hong Kong's Hang Seng declined by 0.13%, China's Shanghai Composite fell by 0.01%, and India's BSE Sensex decreased by 0.68% [7] Notable Stock Movements - PepGen Inc. (NASDAQ: PEPG) shares surged by 89% to $5.03 following the announcement of a $100 million public offering at $3.20 per share [8] - SciSparc Ltd. (NASDAQ: SPRC) shares increased by 101% to $7.71 after announcing a quantum computing-enabled 3D protein modeling initiative [8] - Plus Therapeutics, Inc. (NASDAQ: PSTV) shares rose by 30% to $0.5264 after securing a national coverage agreement with UnitedHealthcare [8] - Stitch Fix, Inc. (NASDAQ: SFIX) shares dropped by 14% to $4.88 after releasing fourth-quarter results [8] - CarMax, Inc. (NYSE: KMX) shares fell by 23% to $43.86 after reporting second-quarter EPS and sales below estimates [8] - Cemtrex, Inc. (NASDAQ: CETX) shares decreased by 31% to $0.4359 following a 1-for-15 reverse stock split approval [8] Economic Indicators - U.S. wholesale inventories declined by 0.2% month-over-month to $898.8 billion in August, contrary to market expectations of a 0.1% increase [11] - U.S. durable goods orders rose by 2.9% month-over-month to $312.1 billion in August, compared to a revised 2.7% decline in July [11] - The U.S. trade deficit in goods decreased by $17.3 billion month-over-month to $85.5 billion in August, better than market estimates [11] - Initial jobless claims fell by 14,000 to 218,000 in the third week of September, below market expectations [11] - The U.S. economy grew at an annualized rate of 3.8% in the second quarter, an increase from the previous estimate of 3.3% [11]

Market Overview - U.S. stocks traded lower, with the Nasdaq Composite falling more than 1% on Thursday, Dow down 0.64% to 45,824.16, NASDAQ down 1.19% to 22,229.54, and S&P 500 down 1% to 6,571.28 [1] - Energy shares increased by 0.5%, while health care stocks decreased by 1.4% [1] Company Earnings - Accenture (NYSE: ACN) reported better-than-expected fourth-quarter 2025 results, with earnings of $3.03 per share, exceeding the analyst consensus estimate of $2.96, and sales of $17.60 billion, slightly above the consensus estimate of $17.36 billion [2] Stock Movements - PepGen Inc. (NASDAQ: PEPG) shares surged 89% to $5.03 after announcing a $100 million public offering at $3.20 per share [8] - SciSparc Ltd. (NASDAQ: SPRC) shares increased by 101% to $7.71 following the announcement of a quantum computing-enabled 3D protein modeling initiative [8] - Plus Therapeutics, Inc. (NASDAQ: PSTV) shares rose 30% to $0.5264 after a national coverage agreement with UnitedHealthcare [8] - Stitch Fix, Inc. (NASDAQ: SFIX) shares fell 14% to $4.88 after releasing fourth-quarter results [8] - CarMax, Inc. (NYSE: KMX) shares dropped 23% to $43.86 after reporting second-quarter EPS and sales below estimates [8] - Cemtrex, Inc. (NASDAQ: CETX) shares declined 31% to $0.4359 after a 1-for-15 reverse stock split approval [8] Commodity Prices - Oil traded down 0.2% to $64.88, gold down 0.2% to $3,761.50, silver up 1.2% to $44.725, and copper down 1% to $4.7660 [5] European Market Performance - European shares were lower, with the eurozone's STOXX 600 down 0.52%, Spain's IBEX 35 down 0.18%, London's FTSE 100 down 0.24%, Germany's DAX 40 down 0.62%, and France's CAC 40 down 0.46% [6] Asian Market Performance - Asian markets closed mostly lower, with Japan's Nikkei 225 gaining 0.27%, while Hong Kong's Hang Seng declined 0.13%, China's Shanghai Composite fell 0.01%, and India's BSE Sensex fell 0.68% [7] Economic Indicators - U.S. wholesale inventories declined by 0.2% month-over-month to $898.8 billion, against market estimates of a 0.1% increase [11] - U.S. durable goods orders increased by 2.9% month-over-month to $312.1 billion, compared to a revised 2.7% decline in July [11] - The U.S. trade deficit in goods shrank by $17.3 billion month-over-month to $85.5 billion, compared to market estimates of $95.65 billion [11] - Initial jobless claims decreased by 14,000 to 218,000, against market estimates of 235,000 [11] - The U.S. economy grew at an annualized rate of 3.8% in the second quarter, up from 3.3% in the second estimate [11]

Market Overview - U.S. stocks traded lower, with the Nasdaq Composite falling more than 1% on Thursday, while the Dow decreased by 0.50% to 45,889.75 and the S&P 500 dropped 0.94% to 6,575.35 [1] - Consumer staples shares increased by 0.5% on Thursday, contrasting with a 1.5% decline in communication services stocks [1][2] Economic Indicators - Initial jobless claims decreased by 14,000 to 218,000 in the third week of September, better than market estimates of 235,000 [3][12] - U.S. wholesale inventories fell by 0.2% month-over-month to $898.8 billion in August, against expectations of a 0.1% increase [12] - Durable goods orders rose by 2.9% month-over-month to $312.1 billion in August, surpassing market estimates of a 0.5% decline [12] - The U.S. trade deficit in goods narrowed by $17.3 billion to $85.5 billion in August, compared to market estimates of $95.65 billion [12] - The U.S. economy grew at an annualized rate of 3.8% in the second quarter, an increase from the previous estimate of 3.3% [12] Commodity Market - Oil prices decreased by 0.5% to $64.66, while gold fell by 0.1% to $3,766.60 [6] - Silver prices increased by 1.4% to $44.805, whereas copper declined by 0.6% to $4.7865 [6] Company Performance - PepGen Inc. shares surged 107% to $5.51 following the announcement of a $100 million public offering priced at $3.20 per share [10] - SciSparc Ltd. shares rose 79% to $6.86 after announcing a quantum computing-enabled 3D protein modeling initiative [10] - Plus Therapeutics, Inc. shares increased by 40% to $0.5640 due to a national coverage agreement with UnitedHealthcare [10] - SeaStar Medical Holding Corporation shares plummeted 50% to $0.6226 after a recommendation to continue a pivotal trial [10] - Erayak Power Solution Group Inc. shares fell 31% to $0.0493 after a previous jump [10] - Cemtrex, Inc. shares dropped 29% to $0.4470 following the approval of a reverse stock split [10]

Market Overview - U.S. stock futures are mixed as investors react to economic data and await comments from Federal Reserve officials, following two days of declines in major indexes due to profit-taking in technology stocks and valuation concerns [1][4][8] - S&P 500 futures are down by approximately 0.18% to 0.4%, while Nasdaq 100 futures show a decline of around 0.13% to 0.6%, and Dow Jones futures are slightly up by about 0.02% to 0.11%, indicating varied investor sentiment [2] Commodity Markets - Crude oil futures are trading lower by approximately 0.46% to 0.7%, around $64.69 per barrel, while gold spot prices have risen about 0.59% to 0.6%, nearing $3,756.88 per ounce, close to its record high [3] Economic Data and Events - Key economic data releases today include weekly jobless claims, second-quarter GDP estimates, durable goods orders, and existing home sales, with stronger data potentially affecting Federal Reserve rate cut expectations [5][6] - The upcoming release of the Personal Consumption Expenditures (PCE) index will be crucial for shaping interest rate expectations [6] Corporate Developments - Intel (INTC) shares gained 1.9% to 3% in pre-market trading as it seeks investment from Apple (AAPL) for its turnaround efforts [7] - Costco Wholesale Corp. (COST) is up 0.43% ahead of its fourth-quarter earnings report [7] - Accenture PLC (ACN) saw a 0.2% rise in pre-market after reporting fourth-quarter revenue slightly above expectations, driven by demand for AI-driven consulting services [7] - CarMax Inc. (KMX) shares initially rose 2% in pre-market but later plunged nearly 12% after missing profit targets [7] - PepGen Inc. (PEPG) shares soared 141% after announcing positive Phase 1 trial results for a treatment [11] - International Business Machines (IBM) stock rose 3.3% following a successful quantum-enabled trading trial [11] - Starbucks (SBUX) stock rose 0.2% after approving a restructuring plan to close underperforming locations [11] - Lithium Americas (LAC) rallied in premarket trading amid reports of talks with the Energy Department and General Motors (GM) regarding a government loan for a lithium project [11]

Core Insights - Premarket trading is showing notable activity with significant price movements indicating potential opportunities for traders [1] Premarket Gainers - PepGen Inc. (PEPG) is up 151% at $6.68 [3] - 22nd Century Group, Inc. (XXII) is up 27% at $1.93 [3] - Immuneering Corporation (IMRX) is up 23% at $11.36 [3] - uniQure N.V. (QURE) is up 10% at $52.58 [3] - Lithium Americas Corp. (LAC) is up 9% at $6.60 [3] - Jasper Therapeutics, Inc. (JSPR) is up 9% at $2.55 [3] - American Shared Hospital Services (AMS) is up 8% at $2.75 [3] - PSQ Holdings, Inc. (PSQH) is up 7% at $3.06 [3] - K Wave Media Ltd. (KWM) is up 7% at $2.48 [3] - ClearPoint Neuro, Inc. (CLPT) is up 5% at $20.48 [3] Premarket Losers - Transocean Ltd. (RIG) is down 14% at $3.11 [4] - Cyclerion Therapeutics, Inc. (CYCN) is down 12% at $2.83 [4] - CarMax, Inc. (KMX) is down 11% at $50.38 [4] - ARB IOT Group Limited (ARBB) is down 11% at $10.45 [4] - SHF Holdings, Inc. (SHFS) is down 10% at $6.49 [4] - Digital Brands Group, Inc. (DBGI) is down 10% at $6.21 [4] - Aqua Metals, Inc. (AQMS) is down 9% at $5.29 [4] - Akanda Corp. (AKAN) is down 8% at $3.96 [4] - Galecto, Inc. (GLTO) is down 8% at $3.88 [4] - Platinum Analytics Cayman Limited (PLTS) is down 7% at $11.12 [4]

Core Points - PepGen Inc. announced an underwritten public offering of common stock and pre-funded warrants, leading to a 112.4% increase in its share price to $5.65 in pre-market trading [1] - Other notable stock movements include OFA Group rising 49.6% to $1.99 due to a partnership announcement, and WORK Medical Technology Group increasing 50.4% to $0.1693 after a significant drop the previous day [5] - Lithium Americas Corp. gained 36.8% to $8.21 following reports of Trump officials seeking an equity stake in the company related to a $2.26 billion loan renegotiation [5] Gainers - Immuneering Corporation rose 30% to $12.00 after pricing a $175 million public offering and a $25 million private placement [5] - 22nd Century Group, Inc. gained 37.7% to $2.08 after securing $9.5 million from an insurance claim settlement [5] - ClearPoint Neuro, Inc. increased by 12.8% to $21.76 after a previous gain of 58% [5] Losers - SeaStar Medical Holding Corporation dipped 43.3% to $0.7035 following a recommendation to continue a pivotal trial [5] - Cemtrex, Inc. shares fell 27.7% to $0.4530 after approving a 1-for-15 reverse stock split [5] - Lunai Bioworks Inc. declined 25.3% to $0.1290 after announcing a 10-for-1 reverse stock split [5]

Group 1 - Costco Wholesale Corporation is expected to report quarterly earnings of $5.80 per share on revenue of $86.11 billion after the market closes [2] - Stitch Fix Inc reported better-than-expected fourth-quarter earnings and provided FY2026 guidance above estimates, but its shares fell 6.6% to $5.27 in after-hours trading [2] - Accenture Plc is anticipated to post earnings of $2.96 per share on revenue of $17.36 billion for the latest quarter, with earnings released before market opening [2] - PepGen Inc announced the launch of an underwritten public offering of common stock and pre-funded warrants, resulting in a 119.6% increase in its shares to $5.84 in after-hours trading [2] - Jabil Inc is expected to report quarterly earnings of $2.92 per share on revenue of $7.59 billion before the market opens, with shares gaining 0.5% to $226.39 in after-hours trading [2]

Core Viewpoint - PepGen Inc. experienced a significant surge in share price, rising 119.55% to $5.84 in after-hours trading following the announcement of an underwritten public offering of common stock and pre-funded warrants [1][2]. Group 1: Public Offering Details - The biotech company based in Cambridge, Massachusetts, has initiated an underwritten public offering, with Leerink Partners and Stifel SF serving as joint book-running managers. The underwriters have a 30-day option to purchase additional shares [2]. - The offering is conducted under a Form S-3 registration statement that was declared effective by the SEC on July 8, 2024 [3]. Group 2: Use of Proceeds - PepGen plans to utilize the net proceeds from the offering to fund ongoing research and clinical development, specifically for the FREEDOM-DM1 and FREEDOM2-DM1 trials targeting neuromuscular diseases. Additional funds will be allocated for working capital and general corporate purposes [4]. Group 3: Market Performance Context - Despite the recent surge, PepGen's stock has faced challenges over the past year, with a decline of 69.11%. The company currently holds a market capitalization of $87.25 million and has an average daily trading volume of 572,850 shares. The stock has fluctuated between a 52-week low of $0.89 and a high of $9.94 [5]. - In regular trading, PEPG closed at $2.66, reflecting a daily increase of 36.41% [5].

Core Viewpoint - Kuehn Law, PLLC is investigating potential breaches of fiduciary duties by certain officers and directors of Sarepta Therapeutics, Inc. related to the misrepresentation of safety risks associated with the ELEVIDYS treatment [1] Group 1: Allegations Against Sarepta Therapeutics - Insiders at Sarepta Therapeutics allegedly caused the company to misrepresent or fail to disclose significant safety risks posed by the ELEVIDYS treatment [1] - The trial regimes and protocols for ELEVIDYS reportedly failed to detect severe side effects, leading to concerns about patient safety [1] - The severity of adverse events from ELEVIDYS treatment may result in the company halting recruitment and dosing in trials, attracting regulatory scrutiny, and increasing risks around the therapy's approvals [1] - Insiders are accused of materially misleading stakeholders and lacking a reasonable basis for their positive statements regarding ELEVIDYS [1]

Core Viewpoint - Kuehn Law is investigating potential breaches of fiduciary duties by officers and directors of Petco Health and Wellness Company, Inc. related to misrepresentation of the company's business model and performance during the pandemic [1]. Summary by Relevant Sections - **Fiduciary Duties Investigation** - Kuehn Law is examining whether certain insiders at Petco misrepresented or failed to disclose critical information regarding the sustainability of the company's pandemic-related growth and its business model focused on premium pet food [1]. - **Misrepresentation of Business Performance** - The investigation highlights that insiders allegedly overstated the strength of Petco's differentiated product strategy and downplayed the severity of issues affecting the company's performance [1]. - **Impact on Financial Statements** - The lawsuit claims that public statements made by Petco were materially false and misleading, affecting the perception of the company's ability to achieve sustainable and profitable growth [1].